HALOZYME THERAPEUTICS, INC.: net_income
| Value | {"amount": -53552000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3faa3217-0a0b-41bb-960e-80e1f4dbbc0f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-15-000041Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/net-income/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3faa3217-0a0b-41bb-960e-80e1f4dbbc0f
History
- supersedes {"amount": -53552002, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001483813-13-000033)